guidelines:
  1: Duval_CIBMTR_Score_for_Acute_Myelogenous_Leukemia_AML_Survival.v1
test_cases:
- id: 1. Zero score
  input:
    1:
      gt0004|Disease group: 0|local::at0015|Primary induction failure or duration of first complete remission >6 months|
      gt0005|Cytogenetics prior to HSCT: 0|local::at0017|Good or intermediate|
      gt0006|HLA match group: 0|local::at0019|HLA identical sibling or well matched or partially matched unrelated|
      gt0007|Circulating blasts: 0|local::at0022|Absent|
      gt0008|Karnofsky or Lanksy scale: 0|local::at0024|90-100|
  expected_output:
    1:
      gt0010|Duval/CIBMTR total score: 0
      gt0011|Score interpretation: local::at0011|3-year overall survival after transplantation is 42%|

- id: 2. Score 1
  input:
    1:
      gt0004|Disease group: 1|local::at0016|Duration of first complete remission <6 months|
      gt0005|Cytogenetics prior to HSCT: 0|local::at0017|Good or intermediate|
      gt0006|HLA match group: 0|local::at0019|HLA identical sibling or well matched or partially matched unrelated|
      gt0007|Circulating blasts: 0|local::at0022|Absent|
      gt0008|Karnofsky or Lanksy scale: 0|local::at0024|90-100|
  expected_output:
    1:
      gt0010|Duval/CIBMTR total score: 1
      gt0011|Score interpretation: local::at0012|3-year overall survival after transplantation is 28%|

- id: 3. Score 2
  input:
    1:
      gt0004|Disease group: 1|local::at0016|Duration of first complete remission <6 months|
      gt0005|Cytogenetics prior to HSCT: 1|local::at0018|Poor|
      gt0006|HLA match group: 0|local::at0019|HLA identical sibling or well matched or partially matched unrelated|
      gt0007|Circulating blasts: 0|local::at0022|Absent|
      gt0008|Karnofsky or Lanksy scale: 0|local::at0024|90-100|
  expected_output:
    1:
      gt0010|Duval/CIBMTR total score: 2
      gt0011|Score interpretation: local::at0013|3-year overall survival after transplantation is 15%|

- id: 4. Score 3
  input:
    1:
      gt0004|Disease group: 1|local::at0016|Duration of first complete remission <6 months|
      gt0005|Cytogenetics prior to HSCT: 1|local::at0018|Poor|
      gt0006|HLA match group: 1|local::at0020|Mismatched unrelated|
      gt0007|Circulating blasts: 0|local::at0022|Absent|
      gt0008|Karnofsky or Lanksy scale: 0|local::at0024|90-100|
  expected_output:
    1:
      gt0010|Duval/CIBMTR total score: 3
      gt0011|Score interpretation: local::at0014|3-year overall survival after transplantation is 6%|

- id: 5. Max score 6
  input:
    1:
      gt0004|Disease group: 1|local::at0016|Duration of first complete remission <6 months|
      gt0005|Cytogenetics prior to HSCT: 1|local::at0018|Poor|
      gt0006|HLA match group: 2|local::at0021|Related other than HLA identical sibling|
      gt0007|Circulating blasts: 1|local::at0023|Present|
      gt0008|Karnofsky or Lanksy scale: 1|local::at0025|<90|
  expected_output:
    1:
      gt0010|Duval/CIBMTR total score: 6
      gt0011|Score interpretation: local::at0014|3-year overall survival after transplantation is 6%|
